Beyond Compliance. Rethinking Drug Safety & Traceability in 2026

In an era of sophisticated counterfeit activity, pharma supply chain leaders are confronting a harder question: does compliance alone ensure real supply chain integrity?

Expert Opinion Paper | 2026

Meet the Experts Behind This Conversation

Dr. Avi Chaudhuri

Founder, The Kulinda Consortium

A long-standing advocate for consumer-centric authentication, Dr. Chaudhuri has worked at the forefront of global anti-counterfeiting efforts for over two decades. His work has influenced serialization and drug identity programs across multiple markets, with a sustained focus on patient-level protection.

Abiram Vijayakumar

Co-Founder, AltiusHub

With a decade-long background in digital transformation and enterprise-scale systems, Abiram Vijayakumar focuses on translating regulatory mandates into resilient supply chain infrastructure. His perspective bridges compliance requirements with long-term system integrity.

Key Themes Covered

The gap between regulatory alignment and real-world drug protection

The evolving sophistication of counterfeit methods and the limits of current safeguards

The distinction between tracking drug movement and verifying identity

Supply chain traceability data ownership, interoperability, and long-term resilience

The leadership decisions shaping the next phase of drug traceability

For Leaders Rethinking Drug Traceability

This conversation is designed for those making high-stakes decisions about how drug traceability processes and systems should evolve within organizations in the years ahead.

Supply Chain & Serialization Leaders

″I need to know whether our systems truly protect patients and brand integrity, not just meet regulatory requirements.

CIO / Digital / IT Leaders

″I need traceability infrastructure that is intelligent, interoperable, and future-ready beyond compliance deadlines.

Packaging Leaders

″I need confidence that authentication practices are robust enough to withstand evolving counterfeit risks

Plant Heads & Operations Leaders

″I need operational confidence that our traceability systems will hold up under real-world pressure, not just on paper.